Kimia Farma Persero Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as wel… Read more
Kimia Farma Persero Tbk (KAEF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.018x
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has a cash flow conversion efficiency ratio of 0.018x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp54.66 Billion) by net assets (Rp3.07 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kimia Farma Persero Tbk - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Kimia Farma Persero Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kimia Farma Persero Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kimia Farma Persero Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Strategic Minerals Plc
PINK:SMCDF
|
0.115x |
|
Steamships Trading Company Ltd
AU:SST
|
0.095x |
|
OpenSys M Bhd
KLSE:0040
|
0.131x |
|
T Scientific Co.Ltd
KQ:057680
|
-0.008x |
|
Hove AS
CO:HOVE
|
-0.033x |
|
Pierre & Vacances
LSE:0OQ0
|
-0.722x |
|
Innovative Technology Development Corp
VN:ITD
|
N/A |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Kimia Farma Persero Tbk (2003–2024)
The table below shows the annual cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp3.43 Trillion | Rp153.62 Billion | 0.045x | +178.56% |
| 2023-12-31 | Rp6.39 Trillion | Rp-364.58 Billion | -0.057x | -232.05% |
| 2022-12-31 | Rp9.34 Trillion | Rp403.34 Billion | 0.043x | +239.48% |
| 2021-12-31 | Rp7.23 Trillion | Rp-223.92 Billion | -0.031x | -121.59% |
| 2020-12-31 | Rp7.11 Trillion | Rp1.02 Trillion | 0.143x | +157.34% |
| 2019-12-31 | Rp7.41 Trillion | Rp-1.85 Trillion | -0.250x | -528.82% |
| 2018-12-31 | Rp3.36 Trillion | Rp195.75 Billion | 0.058x | +359.68% |
| 2017-12-31 | Rp2.57 Trillion | Rp32.64 Billion | 0.013x | -86.50% |
| 2016-12-31 | Rp2.27 Trillion | Rp213.43 Billion | 0.094x | -13.74% |
| 2015-12-31 | Rp1.86 Trillion | Rp202.84 Billion | 0.109x | -31.09% |
| 2014-12-31 | Rp1.81 Trillion | Rp286.31 Billion | 0.158x | +1.18% |
| 2013-12-31 | Rp1.62 Trillion | Rp253.78 Billion | 0.156x | -2.34% |
| 2012-12-31 | Rp1.44 Trillion | Rp230.61 Billion | 0.160x | +138.80% |
| 2011-12-31 | Rp1.25 Trillion | Rp83.91 Billion | 0.067x | -47.21% |
| 2010-12-31 | Rp1.11 Trillion | Rp141.37 Billion | 0.127x | +3.52% |
| 2009-12-31 | Rp995.32 Billion | Rp122.01 Billion | 0.123x | +504.90% |
| 2008-12-31 | Rp947.76 Billion | Rp-28.69 Billion | -0.030x | -149.52% |
| 2007-12-31 | Rp908.03 Billion | Rp55.51 Billion | 0.061x | -62.05% |
| 2006-12-31 | Rp870.65 Billion | Rp140.24 Billion | 0.161x | +344.45% |
| 2005-12-31 | Rp844.22 Billion | Rp30.60 Billion | 0.036x | -91.31% |
| 2003-12-31 | Rp754.46 Billion | Rp314.63 Billion | 0.417x | -- |